CMS Just Tied AI Reimbursement to Health Outcomes: The New Healthcare IT Metric
The new CMS ACCESS model shifts AI valuation from simple deployment to measurable patient outcomes. Discover how healthcare PMOs must adapt.
CMS just tied AI reimbursement to health outcomes. Not deployment. Not adoption. Outcomes.
ACCESS is a new 10-year payment model. It covers diabetes, hypertension, CKD, obesity, depression, and anxiety. Payments unlock only when measurable health goals are met. That's AI measurement embedded directly into the reimbursement model.
65% of U.S. doctors now use AI tools—accounting for 27 million clinical encounters in April alone. Mayo Clinic and Mount Sinai are actively deploying agentic AI for workflow automation.
The Shift in Evaluation
What changes is the fundamental question. It's no longer "did you deploy AI?" It's "did it improve a named health condition?"
The hardest part was always the same: connecting delivery execution to measurable patient outcomes. Not the technology. Not the budget. That connection was always the critical constraint.
ACCESS makes it non-negotiable. This framework is arriving whether your organization is ready or not.
You either own the outcome measurement model, or you're just tracking tasks.